Skip to main content
Clinical Trials/NCT01129115
NCT01129115
Completed
Early Phase 1

Dose Response Study of Exercise for Age-related Cognitive Changes

Jeff Burns, MD1 site in 1 country101 target enrollmentMay 2010

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Alzheimer's Disease
Sponsor
Jeff Burns, MD
Enrollment
101
Locations
1
Primary Endpoint
Visuospatial Processing
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This is a randomized, 26-week study of supervised exercise assessing three doses of exercise in sedentary individuals 65 years of age and over with age-related cognitive changes. A total of 100 subjects (n=25 in each of four groups) will be randomized to a non-aerobic control group, 75 minutes, 150 minutes, or 225 minutes a week of moderate intensity aerobic exercise spread over 3 to 5 days a week for 26 weeks. These exercise doses represent 50%, 100%, or 150% of the recommended exercise dose. Participants will be directly supervised during all exercise sessions for the first two months after which direct supervision will occur during at least one session a week. This is intended to provide increased flexibility while also maintaining direct contact with the participant to enhance adherence. Aerobic fitness, physical function, and cognition will be assessed at baseline and 26 weeks to examine the dose-response relationships.

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
April 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Jeff Burns, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Jeff Burns, MD

Assistant Professor, Director of the Alzheimer & Memory Center & AD Clinical Research Program

University of Kansas Medical Center

Eligibility Criteria

Inclusion Criteria

  • Informed consent
  • Age 65 years or older
  • Underactive or sedentary based on the Telephone Assessment of Physical Activity
  • Community dwelling with a caregiver willing to accompany the participant to visits to the screening evaluation. The caregiver must visit with the subject more than five times a week.
  • Nondemented: Clinical Dementia Rating (CDR) 0
  • Adequate visual and auditory abilities to perform all aspects of the cognitive and functional assessments
  • Stable doses of medications for at least 30 days prior to screening.
  • Likely to participate in all scheduled evaluations and complete the exercise program over 52 weeks

Exclusion Criteria

  • Current clinically significant major psychiatric disorder (e.g., Major Depressive Disorder) according to Diagnostic Statistical Manual (DSM)-IV criteria or Geriatric Depression score of 5 or greater.
  • Significant psychiatric symptoms (e.g., hallucinations) that could impair the completion of the study
  • Current clinically-significant systemic illness likely to result in deterioration of the patient's condition or affect the patient's safety during the study
  • History of clinically-evident stroke
  • Clinically-significant infection within the last 30 days
  • Myocardial infarction or symptoms of coronary artery disease (e.g., angina) in the last two-years.
  • Uncontrolled hypertension within the last 6 months
  • History of cancer within the last 5 years (except non-metastatic basal or squamous cell carcinoma)
  • History of drug or alcohol abuse as defined by DSM-IV criteria within the last 2 years
  • Insulin-dependent diabetes mellitus

Outcomes

Primary Outcomes

Visuospatial Processing

Time Frame: 26 weeks

Visuospatial Processing is a latent derived variable derived estimated mean.The reported latent means for this trial are created from the well-known neuropsychological tests: Block Design, Stroop Color Reading, Digit Symbol Substitution and Trailmaking Test A. Latent variables cannot be measured directly but are derived from a theory-driven confirmatory factor analysis in a structural equation model framework. The latent scores are centered around a mean of 0 and standardized so each value represents a fraction of the standard deviation. There are no limits to the scores. Positive number indicate improved performance. Negative numbers indicate worsening performance.

Change in Maximal Oxygen Consumption

Time Frame: 26 weeks

Maximal Oxygen consumption (VO2 max) is the standard, quantitative measure of aerobic fitness. The physiologic range of scores is approximately 3.5 milliliters of oxygen per kilogram of body weight per minute (ml/kg/min) to approximately 90 (ml/kg/min). Higher numbers indicate greater fitness and positive change indicates increasing fitness. Lower number indicate worse fitness

Change in Physical Performance Test

Time Frame: 26 Week

The Physical Performance Test is a 9-item measure of physical function. The range of scores is 0-34. Higher numbers indicate better physical function. Positive change indicates improving function. Negative change indicates decreasing function.

Secondary Outcomes

  • Verbal Memory(26 weeks)
  • Simple Attention(26 Weeks)
  • Set Maintenance & Shifting(26 Weeks)
  • Reasoning(26 Weeks)

Study Sites (1)

Loading locations...

Similar Trials